Diabetes Mellitus as a Risk Factor for High Grade Renal Cell Carcinoma

被引:11
|
作者
Otunctemur, Alper [1 ]
Ozbek, Emin [3 ]
Sahin, Suleyman [1 ]
Dursun, Murat [2 ]
Besiroglu, Huseyin [1 ]
Koklu, Ismail [1 ]
Erkoc, Mustafa [1 ]
Danis, Eyyup [1 ]
Bozkurt, Muammer [1 ]
Gurbuz, Ahmet [1 ]
机构
[1] Okmeydani Training & Res Hosp, Dept Urol, Istanbul, Turkey
[2] Okmeydani Training & Res Hosp, Dept Urol, Istanbul, Turkey
[3] Katip Celebi Univ, Ataturk Training & Res Hosp, Dept Urol, Izmir, Turkey
关键词
Diabetes; renal cell carcinoma; tumor size; Furhman grade; HgA1c; KIDNEY CANCER; COHORT; EXPRESSION; RECEPTOR; DISEASE; MEN;
D O I
10.7314/APJCP.2014.15.9.3993
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Diabetes is a chronic disease characterized by impaired fasting blood glucose that leads to disturbances in various organs. In this study, we evaluated relationships between tumor size and grade in a population of diabetic and non-diabetic patients with renal cell carcinoma. Materials and Methods: Between 2007-2013, in our clinic radical nephrectomy performed to 310 patients for renal tumors and pathology reported renal cell carcinoma cases were enrolled in the study. Patients with and without a history of diabetes regarding fasting glucose and HgA1c levels were evaluated during surgery for tumor size and Fuhrman grade. Results: Diabetes was found in 95 patients. The mean age of the patients with and without diabetes mellitus was 64.3 (40-79) and 58.4 (31-87) years, respectively. In the diabetes group 51% of patients had a tumor size over 7 cm and 54% a tumor grade over Fuhrman 3. The respective figures in the non-diabetes group were 35% and 30% (p<0.05 in both cases). Conclusions: Renal cancer appears more aggressive in patients with diabetes. In this study lifestyle and risk factors with diabetes regulation were observed to be important for renal cancer patients. Multicenter studies are needed in larger series for more accurate results.
引用
收藏
页码:3993 / 3996
页数:4
相关论文
共 50 条
  • [41] Diabetes Mellitus Type 2-An Independent Risk Factor for Cancer?
    Grote, V. A.
    Becker, S.
    Kaaks, R.
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2010, 118 (01) : 4 - 8
  • [42] Diabetes Mellitus as an Independent Predictor of Survival of Patients Surgically Treated for Renal Cell Carcinoma: A Propensity Score Matching Study
    Lee, Hakmin
    Kwak, Cheol
    Kim, Hyeon Hoe
    Byun, Seok-Soo
    Lee, Sang Eun
    Hong, Sung Kyu
    JOURNAL OF UROLOGY, 2015, 194 (06) : 1554 - 1560
  • [43] Hepatocyte nuclear factor 1 alpha variants as risk factor for hepatocellular carcinoma development with and without diabetes mellitus
    Bedira, Isis Samy
    El Sayed, Ibrahim El Tantawy
    Hendy, Olfat M.
    Abdel-Samiee, Mohamed
    Rashad, Amany Mohamed
    Zaid, Ahmed B.
    GENE REPORTS, 2024, 37
  • [44] Tumor suppressive role of Hippo signaling in high grade clear cell renal cell carcinoma
    Moriyama, Masatsugu
    Kai, Tomoki
    Matsuura, Keiko
    Nomura, Takeo
    Satoh, Fuminori
    Mimata, Hiromitsu
    Takahashi, Mika
    CANCER SCIENCE, 2018, 109 : 17 - 17
  • [45] Thymidine phosphorylase as a prognostic factor in renal cell carcinoma
    Padrik, Peeter
    Saar, Helgi
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2010, 42 (02) : 295 - 298
  • [46] Type II Diabetes Mellitus - Associated Risk Factor in the Onset and Evolution of Digestive Tract Carcinoma
    Nitipir, Cornelia
    Barbu, Maria Alexandra
    Orlov, Cristina
    Stanciu, Adina Elena
    Popa, Ana Maria
    Hainarosie, Razvan
    Pituru, Silviu
    Arsene, Andreea Letitia
    Stoian, Anca Pantea
    ROMANIAN BIOTECHNOLOGICAL LETTERS, 2019, 24 (01): : 140 - 146
  • [47] Diabetes Mellitus with Obesity is a Predictor of Recurrence in Patients with Non-metastatic Renal Cell Carcinoma
    Fukushima, Hiroshi
    Masuda, Hitoshi
    Yokoyama, Minato
    Tatokoro, Manabu
    Yoshida, Soichiro
    Ishioka, Junichiro
    Matsuoka, Yoh
    Numao, Noboru
    Koga, Fumitaka
    Saito, Kazutaka
    Fujii, Yasuhisa
    Kihara, Kazunori
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2013, 43 (07) : 740 - 746
  • [48] High circulating insulin-like growth factor-1 reduces the risk of renal cell carcinoma: a Mendelian randomization study
    Chen, Meng
    Tsai, Chia-Wen
    Chang, Wen-Shin
    Xiong, Grace Y.
    Xu, Yifan
    Bau, Da-Tian
    Gu, Jian
    CARCINOGENESIS, 2021, 42 (06) : 826 - 830
  • [49] Preliminary Construction of Prognostic Risk Early Warning Model for Renal Cell Carcinoma with Type 2 Diabetes Mellitus Based on SMOTE Algorithm
    Liu, Yang
    Meng, Lingling
    Li, Jinawei
    Qi, Guisong
    Song, Miaomiao
    INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2023, 85 : 106 - 112
  • [50] The impact of obesity and diabetes mellitus on the risk of hepatocellular carcinoma
    Polesel, J.
    Zucchetto, A.
    Montella, M.
    Dal Maso, L.
    Crispo, A.
    La Vecchia, C.
    Serraino, D.
    Franceschi, S.
    Talamini, R.
    ANNALS OF ONCOLOGY, 2009, 20 (02) : 353 - 357